Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
Monitoring of Circulating Tumor DNA and Its Aberrant Methylation in the Surveillance of Surgical Lung Cancer Patients (MEDAL, MEthylation Based Dynamic Analysis for Lung Cancer).
- Status
- UNKNOWN
- Phase
- N/A
A Study of Apatinib Plus EGFR-TKI as First Line Treatment in Patients With Non-squamous NSCLC Harboring EGFR Mutations
- Status
- UNKNOWN
- Phase
- NA
Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Combination Study With Soluble LAG-3 Fusion Protein Eftilagimod Alpha (IMP321) and Pembrolizumab in Patients With Previously Untreated Unresectable or Metastatic NSCLC, or Recurrent PD-X Refractory NSCLC or With Recurrent or Metastatic HNSCC
- Status
- COMPLETED
- Phase
- PHASE2
Comprehensive Analysis of Gene Mutation Profile in Chinese NSCLC Patients by Next-generation Sequencing
- Status
- COMPLETED
- Phase
- N/A
Multiparametric PET-MRI Integration for a New Approach to Tumor Heterogeneity in Non-Small Cell Lung Cancer (NSCLC): Pilot Study
- Status
- TERMINATED
- Phase
- NA
A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Prospective Study to Evaluate the Consistency of Next-Generation Sequencing(NGS)-Panels by Using Malignant Hydrothorax Form NSCLC
- Status
- UNKNOWN
- Phase
- N/A
Osimertinib With Stereotactic Radiosurgery (SRS) in Brain Metastases From EGFR Positive NSCLC
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Toripalimab+ Pemetrexed Plus Carboplatin in Patients With EGFR-mutation Positive and T790M Negative After Progression on EGFR-TKI Treatment
- Status
- COMPLETED
- Phase
- PHASE2
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage II to IIIA NSCLC by NGS
- Status
- COMPLETED
- Phase
- N/A
A Study of BCD-135 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Drug Sensitivity Correlation Between Patient-Derived Organoid Model and Clinical Response in NSCLC Patients
- Status
- UNKNOWN
- Phase
- N/A
A Trial of PTS Via Intratumoral Injection in Patients With Central Air Way NSCLC Severe Obstruction
- Status
- COMPLETED
- Phase
- PHASE3
Apatinib Combined With EGFR-TKI for Advanced Slow-progressed EGFR-TKI Resistant NSCLC
- Status
- UNKNOWN
- Phase
- PHASE3
Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE2
TAGRISSO (Osimertinib) in NSCLC Patients in Whom T790 Mutations Are Detected by Liquid Biopsy
- Status
- COMPLETED
- Phase
- PHASE2